The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
CytoMed Therapeutics Limited(NASDAQ:GDTC)


CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers. The company's lead product candidate is CTM-N2D, which consists of expanded gamma delta T cells grafted with natural killer group 2D liga...
Share this website to your friends
CytoMed Therapeutics Days Payable Outstanding ttm (DPO)
CytoMed Therapeutics Days Inventory Outstanding ttm (DIO)
CytoMed Therapeutics Op Cashflow Per Share ttm
CytoMed Therapeutics Free Cashflow Per Share ttm
CytoMed Therapeutics Cash Per Share ttm
CytoMed Therapeutics (GAAP) P/E ratio ttm
CytoMed Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.